During the past decade, Sheffield Institute for Translational Neuroscience (SITraN) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheffield Institute for Translational Neuroscience (SITraN)" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sheffield Institute for Translational Neuroscience (SITraN)" are "Amyotrophic Lateral Sclerosis" (4 trials) and "Mild Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Sheffield Institute for Translational Neuroscience (SITraN)" in a lesser frequency.

Most popular intervention types in "Sheffield Institute for Translational Neuroscience (SITraN)" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMX0035" (2 trials), "Dexpramipexole" (2 trials) and "IONIS MAPTRx" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sheffield Institute for Translational Neuroscience (SITraN)" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Sheffield Institute for Translational Neuroscience (SITraN)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Sheffield Institute for Translational Neuroscience (SITraN), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sheffield Institute for Translational Neuroscience (SITraN), 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".